Clinical Trial

Primary Cardiac Lymphoma: Italian Multicenter Experience

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 5, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The rationale of this study is to provide an overview on PCL (Primary Cardiac Lymphoma) in Italy, trying to shed light on unknown aspects of the disease and on unanswered questions about its management that could be helpful in clinical practice.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-04-06; most recent amendment 2025-12-31.
Status change: Not Yet Recruiting → Recruiting 2024-08-19
Trial Details
NCT Number NCT05819528
Lead Sponsor Fondazione Italiana Linfomi - ETS
Conditions Primary Cardiac Lymphoma
Enrollment 43 participants
Start Date 2024-10-02
Primary Completion 2026-04 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-05